A group of plaintiffs who have filed Viagra skin cancer lawsuits in federal courts are requesting that all pending federal Viagra lawsuits be centralized in a multidistrict litigation. In a December transfer motion, the plaintiffs argued that the Viagra lawsuits in question “assert virtually identical claims against the same Defendant, for the same injury, caused by the same drug.”
Viagra is a phosphodiesterase type 5 (PDE5) inhibitor manufactured by ...
continue reading...Another Viagra melanoma lawsuit has been filed, this time by a California man who claims Pfizer’s drug caused skin cancer to form and spread across his upper body.
Viagra belongs to a group of drugs called phosphodiesterase type 5 (PDE5) inhibitors, which are intended to treat erectile dysfunction in men. Since its approval by the U.S. Food and Drug Administration (FDA) in 1998, Viagra has been prescribed to over ...
continue reading...The Huffington Post reports on a new study that claims Viagra does not lead to increased risk of melanoma, a common form of skin cancer, in men who use it. Instead, the researchers behind the NYU Langone Medical Center study contend that melanoma in Viagra users is the result of lifestyle issues. These findings conflict with those provided by a study in June 2014, ...
According to The Independent, sales of Pfizer, Inc.’s erectile dysfunction (ED) drug Viagra rose 47 percent last year in China. The spike in regional profits comes at a time when Viagra’s global sales are falling due to patent loss and competition from other pharmaceutical giants, like Eli Lilly & Co.
Viagra has been linked in studies to an increased risk of melanoma, a dangerous type of ...
continue reading...Studies have shown that there is a significant correlation between recent users of sildenafil (Viagra) and development of melanoma. In fact, one study of 26,000 men showed that sildenafil users were at almost twice the risk for melanoma compared to those who have never taken the drug. An article by MedPage Today details the findings of the study.
The study, conducted at the Indiana University School of Public Health, identified an 84 percent increased risk of ...
continue reading...
The U.S. Food and Drug Administration has proposed requiring tanning beds to include a label warning that the devices increase the risk of skin cancer and shouldn’t be used by people younger than 18.
According to a USA Today story, the FDA currently regulates the sunlamps in tanning beds as class 1 devices, which are considered low risk and don’t require review before going on the market.
The FDA’s proposal would change ...
continue reading...
